Evidence map›Paper›PMID 35153088›Full record

ArticleVaccine2022

Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications.

Chizoba Wonodi, Chisom Obi-Jeff, Funmilayo Adewumi, Somto Chloe Keluo-Udeke, Rachel Gur-Arie, Carleigh Krubiner, Elana Felice Jaffe, Tobi Bamiduro, Ruth Karron, Ruth Faden

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 4 pooled it
45.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 4 syntheses or guidelines pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. The Drivers of Low Vaccination Utilization in Niger.The American journal of tropical medicine and hygiene · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Chizoba WonodiJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Chisom Obi-JeffDirect Consulting and Logistics Limited Abuja, Federal Capital Territory, Nigeria. Electronic address: chisom.obi@dclnigeria.com.
Funmilayo AdewumiDirect Consulting and Logistics Limited Abuja, Federal Capital Territory, Nigeria.
Somto Chloe Keluo-UdekeWomen Advocates for Vaccine Access Abuja, Federal Capital Territory, Nigeria.
Rachel Gur-ArieBerman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, United States.
Carleigh KrubinerBerman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, United States.
Elana Felice JaffeUniversity of North Carolina, School of Medicine, Chapel Hill, NC, United States.
Tobi BamiduroDirect Consulting and Logistics Limited Abuja, Federal Capital Territory, Nigeria.
Ruth KarronJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Ruth FadenJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Johns Hopkins University · USAchieving Health Nigeria Initiative · NGUniversity of North Carolina at Chapel Hill · US

Funding

Wellcome TrustWellcome Trust 21556/Z/20/Z
6 · The paper itself

Abstract

introductionCOVID-19 vaccine hesitancy is a worldwide phenomenon and a serious threat to pandemic control efforts. Until recently, COVID-19 vaccine hesitancy was not the cause of low vaccine coverage in Nigeria; vaccine scarcity was the problem. As the global supply of COVID-19 vaccines improves in the second half of 2021 and more doses are deployed in Nigeria, the supply/demand dynamic will switch. Vaccine acceptance will become a key driver of coverage; thus, amplifying the impact of vaccine hesitancy. Conspiracy theories and misinformation about COVID-19 are rampant and have been shown to drive vaccine hesitancy and refusal. This study systematically elicits the misinformation and conspiracy theories circulating about COVID-19 among the Nigerian public to understand relevant themes and potential message framing for communication efforts to improve vaccine uptake.

methodsFrom February 1 to 8, 2021, we conducted 22 focus group discussions and 24 key informant interviews with 178 participants from six states representing the six geopolitical zones. Participants were purposively selected and included sub-national program managers, healthcare workers, and community members. All interviews were iteratively analyzed using a framework analysis approach.

resultsWe elicited a total of 33 different conspiracy theories or misinformation that participants had heard about the COVID-19 virus, pandemic response, or vaccine. All participants had heard some misinformation. The leading claim was that COVID-19 was not real, and politicians took advantage of the situation and misused funds. People believed certain claims based on distrust of government, their understanding of Christian scripture, or their lack of personal experience with COVID-19.

conclusionsOur study is the first to report a thematic analysis of the range of circulating misinformation about COVID-19 in Nigeria. Our findings provide new insights into why people believe these theories, which could help the immunization program improve demand generation communication for COVID-19 vaccines by targeting unsubstantiated claims.

Indexed as

COVID-19VaccinesCommunicationCOVID-19 VaccinesHumansNigeriaCOVID-19 VaccinesVaccinesConspiracy theoryCOVID-19 vaccinesDemand generation communicationMisinformationNigeriaRisk communication

Identifiers

PMID35153088
PMCPMC8830779
OpenAlexW4210252023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.